1. VTE Prevention in the Hospital

3. Risk of VTE

4. Who Is at High Risk for VTE?

5. Incorporating the Use of Assessment Tools in the Hospital Setting

6. Which Tool to Use? Common Elements

7. IMPROVE Bleeding Risk Score Calculator

8. Systemwide Approach to VTE Risk Assessment and Prophylaxis

9. Current Treatments for Prophylaxis

10. Current Strategies Are Shifting…

11. APEX Trial: Design Betrixaban vs Enoxaparin

12. APEX Trial Primary Efficacy End Point

13. APEX Trial Fatal Bleeding and ICH

14. MAGELLAN Trial: Primary Efficacy Outcome Events

15. MARINER Trial: Study Design

16. MARINER Trial Primary Efficacy Endpoint

17. MARINER Trial Symptomatic VTE

18. MARINER Trial Bleeding

19. Risk-Benefit in Patients With Renal Insufficiency

20. Improved Safety

21. 2013 IUA Guidelines

22. Clinical Perspective Moving Forward

23. Concluding Remarks

24. Concluding Remarks (cont)

25. Abbreviations

26. Abbreviations (cont)